Cleveland Clinic’s Plan to ‘Flip’ the Medicare Advantage Model

Why It Matters

By assuming premium risk, Cleveland Clinic aims to control costs, improve margins, and reshape provider‑payer dynamics in the growing Medicare Advantage market.

Key Takeaways

• Cleveland Clinic aims for $1.4B Medicare Advantage premiums by 2028
• System will assume delegated premium risk, managing total cost of care
• New capabilities include member panels, HEDIS metrics, AI-driven rule engines
• First-year delegated contracts are near break-even, indicating contract viability
• Clinic targets risk‑delegation deals with UnitedHealthcare and Elevance

Pulse Analysis

Cleveland Clinic’s strategic pivot reflects a broader industry recalibration as hospitals grapple with the financial strain of traditional fee‑for‑service Medicare Advantage contracts. While many health systems are shedding these agreements, the clinic is betting that owning the payer side—by accepting delegated premiums—will let it steer both cost and quality outcomes. The move aligns with a growing emphasis on value‑based care, where providers are incentivized to keep total expenditures low while maintaining high‑quality metrics, a shift that could redefine revenue streams for large academic health systems.

The risk‑delegation model places the clinic directly in charge of a member’s entire care continuum, from primary‑care panels to specialist interventions. Cleveland Clinic’s high Medicare case‑mix index of 3.28 underscores the challenge: managing complex, high‑cost patients while ensuring documentation accurately captures acuity to justify premium allocations. To mitigate risk, the system is deploying point‑of‑care tools, HEDIS‑driven quality dashboards, and collaborative AI rule engines that aim to auto‑adjudicate 95% of claims, dramatically cutting denial rates and administrative waste. Early results show the first year of contracts hovering at break‑even, suggesting the financial architecture of these deals can be calibrated for profitability.

If successful, Cleveland Clinic’s approach could catalyze a new partnership paradigm between providers and the nation’s largest Medicare Advantage carriers, UnitedHealthcare and Elevance. By moving from a transactional, claim‑by‑claim relationship to a shared‑risk framework, both sides stand to lower operating costs, improve star ratings, and enhance patient experience. However, scaling this model will require robust data analytics, disciplined coding practices, and a cultural shift toward joint problem‑solving rather than adversarial negotiations. The clinic’s experiment may become a blueprint for other health systems seeking sustainable growth in a market increasingly driven by value and risk sharing.